Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × poly(I).poly(c12,U) × Clear all

NCT01312389 2021-11-15

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase 1/2 Terminated

3 enrolled 4 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms